Action on human albumin not swift enoughBMJ 1998; 317 doi: https://doi.org/10.1136/bmj.317.7155.367 (Published 08 August 1998) Cite this as: BMJ 1998;317:367
- Caroline White
The Department of Health has dragged its feet over the findings of the Cochrane Injuries Group on human albumin, and it is not providing sufficient interim advice to doctors, according to the principal author of the group's report, Ian Roberts.
Human albumin is used in the emergency treatment of shock, acute management of burns, and clinical situations associated with hypoprotein-aemia. A systematic review showed that albumin administration results in six extra deaths for every 100 patients treated (25 July, p 235p-40).
Dr Roberts claims that he alerted the department to the findings in the first week of April. An emergency meeting …